Seeking VIDS patients who are living with hepatitis B, hepatitis C or HIV to provide blood samples for the development of a new diagnostic test sampling and storage device for resource-poor countries.
The purpose of this study is to assess a novel blood collection device, called a Plasma Separation Device (PSD), which has been developed at the Burnet Institute in Melbourne.
The PSD is designed to collect and store blood samples in remote and resource-poor settings and to assist with infectious diseases testing.
The study team want to measure the effectiveness of the PSD for the diagnosis of hepatitis B, hepatitis C and HIV. They also want to see if the PSD can detect other immune responses to infectious diseases that you have been vaccinated against (for example, measles or tetanus).
Anticipated enrolment close date: April 2020
Who can take part
Inclusion criteria
- Patients presenting to VIDS Specialist Clinics (Outpatients) at Royal Melbourne Hospital, who are living with hepatitis B, hepatitis C or HIV
- People who can provide written informed consent
- Aged 18 years and over
Exclusion criteria
You will be excluded if you:
- Are unable to provide your own consent
- Have had a blood transfusion within the last 12 weeks
What's involved
Two tubes of blood will be taken once only
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.
The Clinical Trials Centre (CTC) is a dedicated, purpose-built space where we conduct clinical trials.
The CTC is located on Level 2 South. When you arrive, if you are unsure where to go, talk to one of our friendly volunteers or the information desk staff.